Vivani Medical, Inc.

NASDAQ:VANI

Medical - Devices

Healthcare
$1.05 +1.30%

+$0.02 today

Market cap
$94.71M
Beta
3.29
P/E (TTM)
-3.5
EPS (TTM)
-$0.33
52W Low $0.92High $1.92

Volume 0.18M

Average 0.24M

VANI Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Vivani Medical, Inc.NASDAQ: VANI

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit turns negative

Q1 FY2026 gross profit was -$130K, compared with $0 a year earlier. Trailing-twelve-month gross profit was -$130K.

Context

  • Gross profit increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly gross profit holds near -$130K or moves back toward the trailing-twelve-month quarterly average of -$32.5K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$130K— QoQ
Last fiscal yearDec 2025
-$424K— YoY
LTMMar 2026
-$130K-46.1% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
(424K) USD
Year-over-year change
—

Gross Profit vs competitors

How VANI compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -46.1% is the lowest of 8, against a peer median of +33.2%.
VANI Competitors
Gross Profit for VANI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RCELAVITA Medical, Inc.LTM Mar 2026$58.86M USD-3.9%+27.5%81.4%
FONRFONAR CorporationLTM Mar 2026$42.41M USD-0.1%-3.0%40.3%
HYPRHyperfine, Inc.LTM Mar 2026$7.85M USD+44.8%+95.3%51.2%
MBOTMicrobot Medical Inc.LTM Mar 2026-$10K USD+61.5%—9.5%
CRDLCardiol Therapeutics Inc.LTM Mar 2026-CA$52.73K CAD+33.2%——
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026-$121K USD+2.4%-83.1%—
VANIVivani Medical, Inc.LTM Mar 2026-$130K USD-46.1%——
IMAImageneBio IncLTM Mar 2026-$780K USD+95.0%——
Peer median (excluding VANI) —+33.2%+12.2%45.7%

Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00357K0424K
Gross Profit00(357K)0(424K)
Gross Margin—————
Research & Development11M14.17M16.97M15.75M18.13M
Selling, General & Admin2.32M5.37M10M8.93M9.43M
Operating Expenses13.32M21.24M26.61M24.68M27.13M
Depreciation & Amortization345K381K357K400K424K
EBITDA(12.43M)(19.16M)(25.3M)(23.09M)(26.19M)
EBITDA Margin—————
Operating Income(13.32M)(21.24M)(26.97M)(24.68M)(27.56M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses550K7.35M1.31M1.19M947K
Income Before Tax(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Net Margin—————
EPS (Basic)(0.33)(0.17)(0.50)(0.43)(0.43)
EPS (Diluted)(0.33)(0.17)(0.50)(0.43)(0.43)
Weighted Avg Shares36.25M38.24M50.85M54.98M62.39M
Weighted Avg Shares (Diluted)36.25M38.24M50.85M54.98M62.39M

Vivani Medical, Inc.

NASDAQ:VANI

Intrinsic Alpha fair value

Locked

Current Price

$1.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.